Buyout firm GTCR is in advanced talks on a potential acquisition of German generic drugmaker Stada Arzneimittel AG, people with knowledge of the matter said. 

Stada was founded in the late 19th century
To read the entire story, you must be logged in.
Please log in now or register with us.